Chronic Kidney Disease
Potential inverse relationship found between phthalates and kidney function in pilot study
Lower cellular respiration found in platelets of patients with CKD
Knowledge gap, lack of counseling pose barriers to contraceptive use among women with CKD
A lack of knowledge about reproductive health and inadequate counseling from physicians were cited as barriers to contraceptive use among women with chronic kidney disease, according to a qualitative study published in Kidney Medicine.
Management of a Patient With Type 2 Diabetes, Stage 3B CKD, and Heart Failure Symptoms
This activity is supported by an educational grant from Novo Nordisk, Inc.
Management of a Patient With a Medical History of Type 2 Diabetes, Hypertension, and Obesity Recently Diagnosed With Stage 3A CKD
This activity is supported by an educational grant from Novo Nordisk, Inc.
Updated recommendations, panel sessions among highlights at 21st annual WCIRDC meeting
Presentations on the latest cardiometabolic research, panel discussions and updated practice recommendations are among this year’s highlights at the 21st World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease.
Two post-approval outcome trials of anti-hyperkalemia drug stopped for logistical reasons
AstraZeneca announced that two post-approval randomized heart- and kidney-related outcome studies of its anti-hyperkalemia drug have been stopped due to slow enrollment and low event rates.
Inflammatory mediators could provide link between obesity, CKD
Study suggests addition of ‘CKD stage 3-plus’ group to care models
FDA issues breakthrough device designation for CKD monitoring tool
AWAK Technologies has received a breakthrough device designation from the FDA for its progression prediction model directed at patients with chronic kidney disease, according to a press release.